Auransa ^Company

Auransa is a clinical stage biopharmaceutical organization that specializes in using artificial intelligence (AI) to discover innovative therapeutics for cancer treatment. Their proprietary AI platform utilizes human disease data to raise the standard of care for cancer patients. The organization is focused on integrating data science into biological discovery and precision medicine. Auransa's co-founder and CEO, Pek Lum, is an early pioneer in genomics technology and is passionate about the intersection of AI, biology, massive data, and precision medicine. The organization is committed to privacy and does not collect personal data or use cookies to collect personally identifiable information from website visitors.